Mondo Visione Worldwide Financial Markets Intelligence

FTSE Mondo Visione Exchanges Index:

News Centre

  • MIAX Business Continuity And Disaster Recovery Plans Testing, Member Designation Standards

    Date 18/12/2020

    As required by Regulation Systems Compliance and Integrity and MIAX Options Rule 321, which is incorporated by reference into both the MIAX Pearl and MIAX Emerald Exchange Rule Books, and thus applicable to Members of both Exchanges, certain Members of the MIAX Exchanges will have mandatory participation requirements in the annual SIFMA Business Continuity Planning Disaster Recovery (“BC/DR”) test. Please refer to the following for more information on designation standards and requirements for Designated Members.

  • CFTC Commitments Of Traders Update

    Date 18/12/2020

    The current reports for the week of December 15, 2020 are now available.


  • Ontario Securities Commission Charges Principals Of Yonge Street Capital LLC With Securities Act Offences

    Date 18/12/2020

    The Ontario Securities Commission (OSC) announced today that Nathanael Anthony Aikman, who currently resides in Coquitlam, British Columbia, and Syed Saad Aziz and Jazib Ali Khan, both from the Toronto, Ontario area, have been charged with offences under the Securities Act (Ontario).

  • MIAX Exchange: Electronic Filing Of Annual Reports

    Date 18/12/2020

    MIAX Exchange Members are reminded that, in connection with the Regulatory Services Agreement between the Exchange and FINRA, the filing of annual reports has been transitioned to the electronic filing platform available via FINRA’s Firm Gateway.

  • SEC Charges Biotech Company And CEO With Fraud Concerning COVID-19 Blood Testing Device

    Date 18/12/2020

    The Securities and Exchange Commission today announced charges against California-based biotechnology company Decision Diagnostics Corp. and its CEO, Keith Berman, with making false and misleading claims in numerous press releases that the company had developed a working, break-through technology that could accurately detect Covid-19 through a quick blood test. The SEC temporarily suspended trading in Decision Diagnostics' securities on April 23, 2020.